Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :10755
Small font sizeDefault font sizeIncrease font size
Navigate here
Resource links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (823 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Figures

 Article Access Statistics
    PDF Downloaded60    
    Comments [Add]    

Recommend this journal


  Table of Contents  
Year : 2019  |  Volume : 56  |  Issue : 4  |  Page : 368-369

Phyllodes-like focus in prostatic hyperplasia

Department of Pathology, The Royal Oldham Hospital, Oldham OL1 2JH, UK

Date of Web Publication11-Oct-2019

Correspondence Address:
John D Coyne
Department of Pathology, The Royal Oldham Hospital, Oldham OL1 2JH
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijc.IJC_477_18

Rights and Permissions

How to cite this article:
Coyne JD. Phyllodes-like focus in prostatic hyperplasia. Indian J Cancer 2019;56:368-9

How to cite this URL:
Coyne JD. Phyllodes-like focus in prostatic hyperplasia. Indian J Cancer [serial online] 2019 [cited 2020 Aug 7];56:368-9. Available from:

Benign nodular prostatic hyperplasia is extremely common but an unusual variant, fibroadenoma-like prostatic hyperplasia, is uncommon. However, foci resembling phyllodes tumor have not previously been described in prostatic hyperplasia. This report highlights this occurrence and its possible association with phyllodes tumor of the prostate.

A 70-year-old man presented with urinary retention. Sequential prostate-specific antigen levels taken over a 10-month period ranged from 6.29 to 7.35 ng/mL. Microscopic examination revealed usual benign nodular and stromal prostatic hyperplasia, mixed acute and chronic inflammation, and a 3-mm focus resembling a benign phyllodes tumor. This focus showed elongated epithelial-lined clefts with several leaf-like, expanded stromal protrusions covered by glandular and basal epithelium with focal squamous metaplasia [Figure 1] and [Figure 2]. The stroma was expanded and mildly hypercellular with subepithelial condensation. Mitotic figures were not seen and there was no evidence of cytological atypia. On further sectioning, the focus cut out.
Figure 1: Epithelial-lined clefts with several leaf-like, expanded stromal protrusions resembling phyllodes tumor

Click here to view
Figure 2: Higher magnification of the phyllodes-like focus

Click here to view

Benign nodular prostatic hyperplasia is extremely common. The fibroadenomatoid variant is rather less, with an apparent incidence of 1%.[1],[2] Nodular hyperplasia with cystic glands and foci resembling fibroadenoma can be misinterpreted as phyllodes tumor.[3] The focus described herein was small, circumscribed, outwith a hyperplastic nodule, and fulfilled the criteria defined by Rosen for distinguishing phyllodes tumors from fibroadenomas.[4]

Moreover, both benign and malignant phyllodes tumors (but not fibroadenomas) have been described in the prostate although their origin and histogenesis have not been well-characterized.[4],[5],[6]

It has been suggested that the leaf-like phyllodes feature is only one of the several patterns seen in lesions termed stromal tumors of uncertain malignant potential (STUMP).[2],[7] However, a number of reports contend that there are no specific criteria in this approach that offer a breakthrough in differential diagnosis.[6] Instead, reports consider that stromal tumors of uncertain malignant potential be reserved for biopsies and that phyllodes tumor should be diagnosed on excised specimens showing appropriate features.[6] In addition, the malignant counterpoint of STUMP with a leaf-like pattern is also termed malignant phyllodes tumor,[2] and grading of such tumors is predictive of outcome in the short term.[8] Of interest, epithelial squamous metaplasia occurs in 10% of breast phyllodes tumors[5] but in only 0.3% of fibroadenomas[9] and is postulated to be more common in benign, as opposed to malignant, prostatic phyllodes tumors.[6] It is unlikely that phyllodes-like foci have a pathogenetic role in prostatic phyllodes and stromal tumors; nevertheless, a phyllodes variant of hyperplasia does appear to exist.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Kafandaris PM, Polyzonis MB. Fibroadenoma-like foci in human prostatic nodular hyperplasia. Prostate 1983;4:33-6.  Back to cited text no. 1
Epstein JI, Cubilla AL, Humphrey PA, editors. EDS Tumours of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum. AFIP Atlas of Tumour Pathology Series 4. Fascicle 14. Washington, DC: ARP Press; 2011.  Back to cited text no. 2
Bostwick DG, Hossain D, Qian J, Neumann RM, Yang P, Young RH, et al. Phyllodes tumor of the prostate: Long-term followup study of 23 cases. J Urol 2004;172:894-9.  Back to cited text no. 3
Bannowsky A, Probst A, Dunker H, Loch T. Rare and challenging tumor entity: Phyllodes tumor of the prostate. J Oncol 2009;2009:241270.  Back to cited text no. 4
Rosen PP, editor. Fibroepithelial neoplasms. In: Breast Pathology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 163-200.  Back to cited text no. 5
Chen TA, Chou JM, Sun GH, Lee HS. Malignant phyllodes tumor of the prostate. Int J Urol 2005;12:1007-9.  Back to cited text no. 6
Fujii T, Shimada K, Tanaka N, Fujimoto K, Konishi N. Phyllodes tumor of the prostate. Pathol Int 2012;62:204-8.  Back to cited text no. 7
Herawi M, Epstein JI. Specialized stromal tumors of the prostate: A clinicopathologic study of 50 cases. Am J Surg Pathol 2006;30:694-704.  Back to cited text no. 8
Kuijper A, Mommers EC, van der Wall E, van Diest PJ. Histopathology of fibroadenoma of the breast. Anat Pathol 2001;115:736-42.  Back to cited text no. 9


  [Figure 1], [Figure 2]


Print this article  Email this article


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow